Nemaura Medical Inc. (NMRD) Financial Statements (2024 and earlier)

Company Profile

Business Address 57 WEST 57TH STREET
MANHATTAN, NY 10019
State of Incorp.
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,01010,1057,34110,11014,75217,749
Cash and cash equivalents4,01010,1057,34110,11014,75217,749
Receivables25441025 218101
Inventory, net of allowances, customer advances and progress billings2,3511,7552,3521,9101,6251,488
Inventory2,3511,7552,3521,9101,6251,488
Prepaid expense      474
Advance royalties  1,000    
Other undisclosed current assets8582681,2171,9341,105276
Total current assets:7,47313,53710,93613,95417,70020,088
Noncurrent Assets
Property, plant and equipment629642    
Intangible assets, net (including goodwill)348384    
Intangible assets, net (excluding goodwill)348384    
Other noncurrent assets   2,0261,9492,0152,013
Total noncurrent assets:9771,0262,0261,9492,0152,013
TOTAL ASSETS:8,45014,56312,96215,90319,71522,102
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities25732717130193136
Accounts payable25732717130193136
Deferred revenue1271247071178259
Debt16,96816,94311,51317,19715,87019,189
Due to related parties 122  
Other liabilities   391398438999
Other undisclosed current liabilities4,3034,8751,0762,0661,280 
Total current liabilities:21,65422,26813,22020,15517,85820,583
Noncurrent Liabilities
Long-term debt and lease obligation1193,0888,5583,4914,700 
Long-term debt, excluding current maturities1193,0888,5583,4914,700 
Other undisclosed noncurrent liabilities 1,0541,0221,0439561,0251,053
Total noncurrent liabilities:1,1734,1099,6004,4475,7251,053
Total liabilities:22,82826,37722,82024,60223,58321,636
Equity
Equity, attributable to parent(14,378)(11,814)(9,859)(8,699)(3,868)466
Common stock292924242424
Additional paid in capital40,99140,99138,29638,29638,29638,296
Accumulated other comprehensive loss(920)(959)(987)(1,543)(567)(122)
Accumulated deficit(54,478)(51,875)(47,192)(45,476)(41,620)(37,731)
Total equity:(14,378)(11,814)(9,859)(8,699)(3,868)466
TOTAL LIABILITIES AND EQUITY:8,45014,56312,96215,90319,71522,102

Income Statement (P&L) ($ in thousands)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
Revenues   374 504
Cost of revenue
(Cost of Goods and Services Sold)
  (0)(3)(72)  
Other undisclosed gross profit  (1,478)    
Gross profit:  (1,478)02  
Operating expenses(2,058)(2,809)(633)(2,240)(2,437)(4,523)
Other undisclosed operating income 224    160
Operating loss:(1,834)(4,287)(633)(2,238)(2,437)(4,363)
Loss from continuing operations before equity method investments, income taxes:(1,834)(4,287)(633)(2,238)(2,437)(4,363)
Other undisclosed loss from continuing operations before income taxes  (4,549)   (5,746)
Loss from continuing operations before income taxes:(1,834)(8,835)(633)(2,238)(2,437)(10,109)
Other undisclosed income from continuing operations  38   350
Loss from continuing operations:(1,834)(8,798)(633)(2,238)(2,437)(9,759)
Loss before gain (loss) on sale of properties:(9,759)
Other undisclosed net loss (769)(38) (1,617)  
Net loss:(2,603)(8,835)(633)(3,856)(2,437)(9,759)
Other undisclosed net income (loss) attributable to parent 4,152(1,083) (1,452) 
Net loss available to common stockholders, diluted:(2,603)(4,683)(1,716)(3,856)(3,889)(9,759)

Comprehensive Income ($ in thousands)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
Net loss:(2,603)(8,835)(633)(3,856)(2,437)(9,759)
Other undisclosed comprehensive loss      (440)
Comprehensive loss:(2,603)(8,835)(633)(3,856)(2,437)(10,199)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent404,180(527)(975)(1,897)(174)
Comprehensive loss, net of tax, attributable to parent:(2,564)(4,655)(1,160)(4,831)(4,334)(10,373)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: